ArticleJournal of bone oncology2012

Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro.

Miki Oda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.